Department of Neurosurgery, Cork University Hospital, Cork, Republic of Ireland.
Acta Neurochir (Wien). 2012 Nov;154(11):2083-8; discussion 2088-9. doi: 10.1007/s00701-012-1483-1. Epub 2012 Aug 30.
The usage of a drain following evacuation of a chronic subdural haematoma (CSDH) is known to reduce recurrence. In this study we aim to compare the clinical outcomes and recurrence rate of utilising two different types of drains (subperiosteal and subdural drain) following drainage of a CSDH.
Prospective randomised single-centre study analysing 50 patients who underwent CSDH treatment. Two types of drains, subperiosteal (SPD) and subdural (SDD), were utilised on consecutive alternate patients following burr-hole craniostomy, with a total of 25 patients in each group. The drains were left in for 48-h duration and then removed. The modified Rankin Scale (mRS) was used for outcome measurement at 3 and 6 months.
Data analysis was performed by unpaired t test with Welch's correction. It was observed that none of the patients in either group had haematoma recurrence during a 6-month follow-up, and a significant difference in outcome was noted at 6 months (p = 0.0118) more than at 3 months (p = 0.0493) according to the statistical analysis. Postoperative seizure and inadvertent placement of the subdural drain into the brain parenchyma were the two complications noted in this study. Anticoagulant use prior to the surgery did not affect the outcome in either group.
We conclude there was no recurrence of CSDH utilising the SDD and SPD following burr-hole craniostomy. The mRS measurement at the 6-month follow-up was found to be statistically significant, with better outcomes with utilisation of the SPD. The SPD may thus prove to be more beneficial than the SDD in the treatment of CSDH. A multi-centre study with a larger group of patients is recommended to reinforce the results from our study.
慢性硬脑膜下血肿(CSDH)引流后使用引流管已被证实可降低复发率。本研究旨在比较颅骨钻孔术后使用两种不同类型引流管(骨膜下和硬脑膜下引流管)治疗 CSDH 的临床效果和复发率。
前瞻性随机单中心研究分析了 50 例接受 CSDH 治疗的患者。颅骨钻孔术后,连续交替使用两种引流管(骨膜下引流管[SPD]和硬脑膜下引流管[SDD]),每组 25 例。引流管留置 48 小时后拔除。采用改良 Rankin 量表(mRS)在 3 个月和 6 个月时评估预后。
采用配对 t 检验(Welch 校正)进行数据分析。结果显示,两组患者在 6 个月的随访中均无血肿复发,且在 6 个月时的预后(p=0.0118)明显优于 3 个月时(p=0.0493)。根据统计学分析。术后癫痫发作和意外将硬脑膜下引流管置入脑实质是本研究中观察到的两种并发症。术前使用抗凝剂在两组中均未影响预后。
我们得出结论,颅骨钻孔术后使用 SDD 和 SPD 均未发生 CSDH 复发。6 个月随访时 mRS 测量结果具有统计学意义,使用 SPD 的预后更好。因此,与 SDD 相比,SPD 在 CSDH 的治疗中可能更有益。建议进行一项多中心、更大样本量的研究,以验证我们的研究结果。